Bosh sahifa000963 • SHE
add
Huadong Medicine Co., Ltd.
Yopilish kursi
40,36 ¥
Kunlik diapazon
40,21 ¥ - 41,20 ¥
Yillik diapazon
25,96 ¥ - 45,92 ¥
Bozor kapitalizatsiyasi
70,79 mlrd CNY
Oʻrtacha hajm
15,62 mln
Narx/foyda
20,05
Dividend daromadliligi
2,28%
Asosiy maydon
SHE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,74 mlrd | 3,12% |
Joriy xarajat | 2,39 mlrd | 8,12% |
Sof foyda | 914,71 mln | 6,06% |
Sof foyda marjasi | 8,52 | 2,90% |
Har bir ulushga tushum | 0,51 | 7,06% |
EBITDA | 1,33 mlrd | 1,60% |
Amaldagi soliq stavkasi | 17,28% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,71 mlrd | 4,18% |
Jami aktivlari | 39,45 mlrd | 14,45% |
Jami passivlari | 14,88 mlrd | 24,24% |
Umumiy kapital | 24,56 mlrd | — |
Tarqatilgan aksiyalar | 1,75 mlrd | — |
Narxi/balansdagi bahosi | 2,94 | — |
Aktivlardan daromad | 7,38% | — |
Kapitaldan daromad | 10,60% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 914,71 mln | 6,06% |
Operatsiyalardan naqd pul | -832,73 mln | -71,87% |
Sarmoyadan naqd pul | -645,84 mln | 8,70% |
Moliyadan naqd pul | -86,84 mln | -221,46% |
Naqd pulning sof oʻzgarishi | -1,57 mlrd | -42,20% |
Boʻsh pul | -1,92 mlrd | -59,30% |
Haqida
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share capital of 380,000,000 renminbi and a market capitalization of 126,323,040 renminbi as of July 2005. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.
In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
Tashkil etilgan
31-mar, 1993
Xodimlar soni
18 265
